SEP 12, 2020 6:00 AM PDT

Treating cancer with the botanical andrographis

A study from City of Hope published in the journal Carcinogenesis reports that the use of the natural botanical Andrographis paniculate in conjunction with chemotherapy could kill chemo-resistant colorectal cancer cells. Chemo-resistant cancers are especially difficult to overcome and patients have very limited options of treatment. Currently, it is estimated that as high as 50–60% of colorectal cancer patients develop resistance to the standard 5-fluorouracil (5FU)-based chemotherapeutic regimens.

Photo: Pexels

Andrographis paniculate offers a non-toxic alternative that can be used in combination with chemotherapy, suggests the new research. The botanical is known for its anti-inflammatory, antibacterial, and antiviral properties and is popular in South Asia. Recent studies have also looked at its anticancer properties.

"Many, many scientific articles have been published showing that Andrographis kills cancer cells. That's not the news," said corresponding author Ajay Goel, Ph.D., M.S., who is founding chair of City of Hope's Department of Molecular Diagnostics and Experimental Therapeutics. "The problem is, how do we kill these 'super cells' that have become chemo-resistant?"

In conducting the study, the group used cell lines to test the outcome of experiments involving the combination of Andrographis with 5-fluorouracil (5FU). Following these cell line experiments, they conducted similar tests in animal models and 3D-organoid models. In all three levels of experiments, the combination of Andrographis with 5FU outperformed the 5FU standard treatment on its own in killing cancer cells.

The researchers determined that Andrographis works by interfering with two major cell signaling pathways – the ferroptosis pathway that regulated programmed cell death, and the β-catenin/Wnt-signaling pathway, which involves cell metabolism. In cancer cells, both of these pathways are on the fritz.

"In cancer, there are hundreds of pathways that are malfunctioning, and modern therapies are designed to target a specific gene or molecule or pathway," Goel said. "It can give patients relief in the short term, but sometimes the cancer says, 'No problem. We have 100 different ways to survive.' Unlike many of the targeted therapies we use in cancer patients, natural treatments are unique, as they don't target a specific pathway but work on many pathways."

"After exposure to Andrographis, the ferroptosis signals were turned back on, which told the cells, 'Yep, it's time to die,'" Goel said. "And the metabolic process was regulated, taking nutrition away from the cancer cells, allowing them to die."

The researchers say the next step in their continued investigation, pending FDA approval, will be to further their experiments in clinical trials. They have hope that their findings will have serious implications for chemo-resistant patients.  

Sources: Carcinogenesis, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
APR 14, 2021
Cancer
Fighting back against medulloblastoma with naturally-occurring compound
APR 14, 2021
Fighting back against medulloblastoma with naturally-occurring compound
Renewed hope for young children with medulloblastoma comes in the form of a research paper published from the Queen Mary ...
APR 08, 2021
Cancer
What can modifiying cultured cells to act more like normal cells teach us about cancer?
APR 08, 2021
What can modifiying cultured cells to act more like normal cells teach us about cancer?
A team from the University of Louisville has developed a technique to make cell cultures act more like normal cells. Thi ...
MAY 05, 2021
Cancer
Developing Therapies to Combat Drug-Resistant Cell States
MAY 05, 2021
Developing Therapies to Combat Drug-Resistant Cell States
Drug resistant tumors present challenges in cancer treatment A significant challenge in the treatment of cancers is the ...
MAY 08, 2021
Cancer
More evidence supports the evils of sugary drinks
MAY 08, 2021
More evidence supports the evils of sugary drinks
New research published online in the journal Gut from researchers at the Washington University School of Medicine i ...
MAY 10, 2021
Cell & Molecular Biology
Getting RNA-Based Medicine Past the Blood-Brain Barrier
MAY 10, 2021
Getting RNA-Based Medicine Past the Blood-Brain Barrier
RNA molecules serve several functions, one of which is to help the cell generate proteins from active genes. It also may ...
JUN 09, 2021
Technology
Computer Program Generates Effective, Clinically-valid Treatment Plans for Cancer Patients
JUN 09, 2021
Computer Program Generates Effective, Clinically-valid Treatment Plans for Cancer Patients
In a recent study published in Nature Medicine, researchers at the Princess Margaret Cancer Centre offer evidence for th ...
Loading Comments...